BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2859533)

  • 1. 3H-TVX Q 7821: identification of 5-HT1 binding sites as target for a novel putative anxiolytic.
    Dompert WU; Glaser T; Traber J
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):467-70. PubMed ID: 2859533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the putative anxiolytic TVX Q 7821 to hippocampal 5-hydroxytryptamine (5-HT) recognition sites.
    Glaser T; Traber J
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):211-5. PubMed ID: 3160954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoradiographic identification and topographical analyses of high affinity serotonin receptor subtypes as a target for the novel putative anxiolytic TVX Q 7821.
    Glaser T; Rath M; Traber J; Zilles K; Schleicher A
    Brain Res; 1985 Dec; 358(1-2):129-36. PubMed ID: 2866816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821.
    Traber J; Davies MA; Dompert WU; Glaser T; Schuurman T; Seidel PR
    Brain Res Bull; 1984 Jun; 12(6):741-4. PubMed ID: 6541079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the putative anxiolytic SM-3997 recognition sites in rat brain.
    Shimizu H; Tatsuno T; Hirose A; Tanaka H; Kumasaka Y; Nakamura M
    Life Sci; 1988; 42(24):2419-27. PubMed ID: 2897609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.
    Walker EA; Yamamoto T; Hollingsworth PJ; Smith CB; Woods JH
    J Pharmacol Exp Ther; 1991 Nov; 259(2):772-82. PubMed ID: 1941625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
    Peroutka SJ; Snyder SH
    Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes.
    Waeber C; Schoeffter P; Palacios JM; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):595-601. PubMed ID: 2975354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction of the anxiolytic agent buspirone with serotonin and other synaptic receptors in the human brain].
    Korneev AIa; Faktor MI; Chan TB
    Biull Eksp Biol Med; 1988 Jan; 105(1):41-3. PubMed ID: 2892547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex.
    Peroutka SJ
    J Neurochem; 1986 Aug; 47(2):529-40. PubMed ID: 2942638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
    Pranzatelli MR
    Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution of serotonin binding sites in the hippocampal region of the rat brain. An autoradiographic study.
    Köhler C
    Neuroscience; 1984 Nov; 13(3):667-80. PubMed ID: 6527773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoaffinity labeling of the 5-hydroxytryptamine 1A receptor in rat hippocampus.
    Ransom RW; Asarch KB; Shih JC
    J Neurochem; 1986 Oct; 47(4):1066-72. PubMed ID: 3746296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
    Pranzatelli MR; Gregory CM
    Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilisation of the 5-hydroxytryptamine3 receptor from pooled rat cortical and hippocampal membranes.
    McKernan RM; Quirk K; Jackson RG; Ragan CI
    J Neurochem; 1990 Mar; 54(3):924-30. PubMed ID: 2303819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
    Ransom RW; Asarch KB; Shih JC
    J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High affinity binding of 3H rauwolscine and 3H RX781094 to alpha 2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes.
    Convents A; Convents D; De Backer JP; De Keyser J; Vauquelin G
    Biochem Pharmacol; 1989 Feb; 38(3):455-63. PubMed ID: 2563652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
    Khawaja X; Ennis C; Minchin MC
    Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.